COPD patients are more likely to also have diabetes. Here the authors show that the use of SGLT2 inhibitors was associated with reduced all-cause mortality, hospitalization, acute exacerbations, and pneumonia in patients with COPD and diabetes.
- Jheng-Yan Wu
- Khai-Chi Hu
- Chih-Cheng Lai
